Items Tagged ‘pomalidomide’

January 26th, 2015

Further Findings Show Pomalyst plus Low-Dose Dexamethasone Safe and Effective in Relapsed or Refractory Multiple Myeloma


For patients with relapsed or refractory multiple myeloma, treatment with Pomalyst® (pomalidomide) plus low-dose dexamethasone appears safe and effective. These findings were presented at the 56th American Hematological Society Annual Meeting and Exposition, December 6–9, 2014, in San Francisco, California.[1] Multiple myeloma is a cancer of plasma cells, which are a special type of white […]

View full entry

Tags: Multiple Myeloma, News, pomalidomide, pomalyst, Recurrent Multiple Myeloma, refractory